电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

Recombinant TNFRSF4 (Telazorlimab Biosimilar) 抗体

The Human 单克隆 anti-TNFRSF4 (Telazorlimab Biosimilar) antibody (ABIN7676097) specifically detects TNFRSF4 (Telazorlimab Biosimilar) in BLI, ELISA, FACS, Func 和 SPR. The antibody is reactive with 人 samples.
产品编号 ABIN7676097
发货至: 中国
Contact our Customer Service for availability and price in your country. Contact Info

Our Local Distributor

中国
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
4A Biotech Co.,Ltd.
Tel +86 (0512) 65829739 传真 +86 (010) 6788 5057

Quick Overview for Recombinant TNFRSF4 (Telazorlimab Biosimilar) 抗体 (ABIN7676097)

抗原

TNFRSF4 (Telazorlimab Biosimilar)

抗体类型

Recombinant Antibody

适用

宿主

  • 1
Human

克隆类型

  • 1
单克隆

标记

  • 1
This TNFRSF4 (Telazorlimab Biosimilar) antibody is un-conjugated

应用范围

Bio-Layer Interferometry (BLI), ELISA, Flow Cytometry (FACS), Functional Studies (Func), Surface Plasmon Resonance (SPR)
  • Expression System

    CHO Cells

    原理

    Anti-TNFRSF4 / OX40 / CD134 Reference Antibody (telazorlimab)

    序列

    QVTLKESGPA LVKPTQTLTL TCSFSGFSLS TSGMGVGWIR QPPGKALEWI AHIWWDDDKY YNTALKTRLT ISKDTSKNQV VLTMTNMDPV DTATYYCARI DWDGFAYWGQ GTLVTVSSAS TKGPSVFPLA PSSKSTSGGT AALGCLVKDY FPEPVTVSWN SGALTSGVHT FPAVLQSSGL YSLSSVVTVP SSSLGTQTYI CNVNHKPSNT KVDKKVEPKS CDKTHTCPPC PAPELLGGPS VFLFPPKPKD TLMISRTPEV TCVVVDVSHE DPEVKFNWYV DGVEVHNAKT KPREEQYNST YRVVSVLTVL HQDWLNGKEY KCKVSNKALP APIEKTISKA KGQPREPQVY TLPPSRDELT KNQVSLTCLV KGFYPSDIAV EWESNGQPEN NYKTTPPVLD SDGSFFLYSK LTVDKSRWQQ GNVFSCSVMH EALHNHYTQK SLSLSPGK,EIVLTQSPAT LSLSPGERAT LSCRASSSVS YMHWYQQKPG QAPRPWIYAT SNRATGIPAR FSGSGSGTDY TLTISSLEPE DFAVYYCQQW SSNPWTFGQG TKVEIKRTVA APSVFIFPPS DEQLKSGTAS VVCLLNNFYP REAKVQWKVD NALQSGNSQE SVTEQDSKDS TYSLSSTLTL SKADYEKHKV YACEVTHQGL SSPVTKSFNR GEC

    产品特性

    Anti-TNFRSF4 / OX40 / CD134 Reference Antibody (telazorlimab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.

    纯度

    >95 %

    亚型

    IgG1
  • 应用备注

    Optimal working dilution should be determined by the investigator.

    说明

    Therapeutic Agents by Target and Mechanism: OX40 inhibitors

    限制

    仅限研究用
  • 状态

    Lyophilized

    浓度

    1 mg/mL

    缓冲液

    25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

    储存条件

    4 °C,-80 °C

    储存方法

    +4°C,-80°C
  • 抗原

    TNFRSF4 (Telazorlimab Biosimilar)

    物质类

    Biosimilar

    分子量

    145.5 kDa

    UniProt

    P43489
You are here: